{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-000168","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2024-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.961062+00:00","generated_at":"2026-06-07T00:52:43.160723+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Sonoma provides January 2024 investor presentation; no material new financial data","bullets":["Presentation reiterates stabilized HOCl platform for dermatology, wound, eye, nasal, oral, animal health.","Products sold in 55 countries directly or through distribution partners.","Company actively seeking additional distribution partners to expand global reach."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-000168","json":"https://secwatch.observer/filing/0001683168-24-000168.json","markdown":"https://secwatch.observer/filing/0001683168-24-000168.md","text":"https://secwatch.observer/filing/0001683168-24-000168.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824000168/0001683168-24-000168-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824000168/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:52:43.160723+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}